The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MIRACLE1: Phase II study of radiotherapy followed by CapeOx and tirelizumab as first-line treatment in MSS rectal cancer with synchronous resectable liver/lung metastases.
 
Zezhi Shan
No Relationships to Disclose
 
Menglong Zhou
No Relationships to Disclose
 
Zilan Ye
No Relationships to Disclose
 
Weijing He
No Relationships to Disclose
 
Yufei Yang
No Relationships to Disclose
 
Dakui Luo
No Relationships to Disclose
 
Fan Xia
No Relationships to Disclose
 
Lijun Shen
No Relationships to Disclose
 
Yikuan Chen
No Relationships to Disclose
 
Changming Zhou
No Relationships to Disclose
 
Qingguo Li
No Relationships to Disclose
 
Zhen Zhang
No Relationships to Disclose
 
Xinxiang Li
No Relationships to Disclose